Donation supports ‘omics’ health research

Alfred Voytek is helping support health research at McMaster with a donation in excess of $500,000 towards research, including the use of new technologies to uncover the genomic, metabolomic and gut microbiomic signatures of future disease development.

October 13, 2017

Experts Featured In This Story

Sonia Anand
Sonia Anand

Professor

See Profile
Paul O'Byrne
Paul O'Byrne

Dean and Vice-President

See Profile

Philanthropist and local businessman Alfred (Fred) Voytek is helping support health research at McMaster University with a donation in excess of $500,000 towards research in the area of ‘omics’, which includes the use of new technologies to uncover the genomic, metabolomic and gut microbiomic signatures of future disease development.

Along with his excitement of the future potential for new discoveries in this area, Mr. Voytek is sympathetic to the difficult funding climate facing health researchers in Canada.

He was intrigued to learn of some of the research led by McMaster University professor Sonia Anand, Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and senior scientist at the Population Health Research Institute. Dr. Anand leads the NutriGen Alliance made up of several birth cohort studies including South Asians and Aboriginal peoples.

“Fred Voytek’s generosity is amazing,” said Anand, noting his support will enable initiation of multi-ethnic studies of ‘omic’ influences on cardio-metabolic traits including adiposity, insulin resistance and metabolic syndrome.

“Dr. Anand is doing wonderful work, and I wanted to support it,” said Voytek.

“Mr. Voytek’s generous support will propel innovative and fundamentally important projects that are key to the future health of Canadians,” added Paul O’Byrne, dean and vice-president of McMaster’s Faculty of Health Sciences.

Three rows of students in a happy group picture at iGEM 2025, holding up a plaque with McMaster University's name on it

McMaster iGEM team wins gold medal for at-home test that signals transplant rejection

One of 400 teams at the international synthetic biology competition, the students presented their at-home kit that offers an early warning if the body is rejecting a kidney transplant, allowing for timely interventions.
An out-of-focus patient in the background is connected to a ventilator, in the foreground

Inexpensive drug that prevents bleeding could save thousands of dollars in care

Giving ventilated ICU patients pantoprazole, which costs as little as 50 cents a day, prevents complications that prove costly for patients' health and health-care systems.
Eric Brown beside a tree trunk with fungi growing on it.

Recent awards power two new studies into drug discovery and development  

Backed by premier research funding programs, the collaborations between McMaster and Kapoose Creek Bio will fast-track the development of an all-new drug candidate that targets neurological conditions, like depression.